BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19040998)

  • 1. Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway.
    Ning L; Kunnimalaiyaan M; Chen H
    Surgery; 2008 Dec; 144(6):920-4; discussion 924-5. PubMed ID: 19040998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
    Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
    Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
    Arthan D; Hong SK; Park JI
    Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
    Park JI; Strock CJ; Ball DW; Nelkin BD
    Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
    Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
    Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
    Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
    Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway.
    Kimata M; Michigami T; Tachikawa K; Okada T; Koshimizu T; Yamazaki M; Kogo M; Ozono K
    Bone; 2010 Nov; 47(5):938-47. PubMed ID: 20709201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.
    Wang S; Zhang X; Wang G; Cao B; Yang H; Jin L; Cui M; Mao Y
    BMC Cancer; 2019 Nov; 19(1):1160. PubMed ID: 31783811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
    Park JI; Strock CJ; Ball DW; Nelkin BD
    Cytokine; 2005 Feb; 29(3):125-34. PubMed ID: 15613280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
    Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
    Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells.
    Carson-Walter EB; Smith DP; Ponder BA; Baylin SB; Nelkin BD
    Oncogene; 1998 Jul; 17(3):367-76. PubMed ID: 9690518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
    Romerio F; Riva A; Zella D
    Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
    Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
    J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
    Su B; Bu Y; Engelberg D; Gelman IH
    J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of L-SIGN with hepatitis C virus envelope protein E2 up-regulates Raf-MEK-ERK pathway.
    Zhao LJ; Wang W; Ren H; Qi ZT
    Cell Biochem Biophys; 2013 Jul; 66(3):589-97. PubMed ID: 23292357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyphosate induces autophagy in hepatic L8824 cell line through NO-mediated activation of RAS/RAF/MEK/ERK signaling pathway and energy metabolism disorders.
    Zhang L; Chen L; Qi M; Yu F; Ni X; Hong H; Xu H; Xu S
    Fish Shellfish Immunol; 2023 Jun; 137():108772. PubMed ID: 37100311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute, chronic and withdrawal effects of the cannabinoid receptor agonist WIN55212-2 on the sequential activation of MAPK/Raf-MEK-ERK signaling in the rat cerebral frontal cortex: short-term regulation by intrinsic and extrinsic pathways.
    Moranta D; Esteban S; García-Sevilla JA
    J Neurosci Res; 2007 Feb; 85(3):656-67. PubMed ID: 17139682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.